The Current Ratio as of December 2025 (TTM) for Swedish Orphan Biovitrum AB (publ) (BIOVF) is 1.02

According to Swedish Orphan Biovitrum AB (publ)’s latest financial reports and current stock price. The company's current Current Ratio is 1.02. This represents a change of 0.69% compared to the average of 1.01 of the last 4 quarters.

Swedish Orphan Biovitrum AB (publ) (BIOVF) Historical Current Ratio (quarterly & annually)

How has BIOVF Current Ratio performed in the past?

The mean historical Current Ratio of Swedish Orphan Biovitrum AB (publ) over the last ten years is 1.16. The current 1.02 Current Ratio has changed 8.65% with respect to the historical average. Over the past ten years (40 quarters), BIOVF's Current Ratio was at its highest in in the March 2016 quarter at 2.13. The Current Ratio was at its lowest in in the June 2023 quarter at 0.59.

Swedish Orphan Biovitrum AB (publ) (BIOVF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Swedish Orphan Biovitrum AB (publ) Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Swedish Orphan Biovitrum AB (publ) (BIOVF) Average Current Ratio

How has BIOVF Current Ratio performed in the past?

The current Current Ratio of Swedish Orphan Biovitrum AB (publ) (BIOVF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Swedish Orphan Biovitrum AB (publ) (BIOVF) Current Ratio vs. Peers

How is BIOVF’s Current Ratio compared to its peers?

Swedish Orphan Biovitrum AB (publ)’s Current Ratio is greater than Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (0.92), less than CSPC Pharmaceutical Group Limited (2.24), less than Orion Oyj (1.86), less than Recordati Industria Chimica e Farmaceutica S.p.A. (1.47), less than Eisai Co., Ltd. (2.09), less than Eisai Co., Ltd. (2.09), less than CSPC Pharmaceutical Group Limited (2.24), less than Eurofins Scientific SE (1.26), greater than Bangkok Dusit Medical Services Public Company Limited (0.93), less than Grifols, S.A. (2.64),

Build a custom stock screener for Swedish Orphan Biovitrum AB (publ) (BIOVF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Swedish Orphan Biovitrum AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Swedish Orphan Biovitrum AB (publ) (BIOVF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Swedish Orphan Biovitrum AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.